Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein

Journal of Surgical Oncology

Volumn 80, Issue 3, 2002, Pages 143-148

  Itamoto, Toshiyuki ^a   Nakahara, Hideki ^a   Tashiro, Hirotaka ^a   Haruta, Naoki ^a   Asahara, Toshimasa ^a   Naito, Akira ^a   Ito, Katsuhide ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

5 FU; Cancer chemotherapy; CDDP; Hepatocellular carcinoma; Portal vein; Tumor thrombus

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER COMBINATION CHEMOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; EVALUATION; FEMALE; HUMAN; LIVER CELL CARCINOMA; MALE; MEASUREMENT; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURVIVAL TIME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HEPATIC ARTERY; HUMANS; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; PORTAL VEIN;

EID: 0036307911     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.10116     Document Type: Article

References (25)

1. Early recognition of hepatocellular carcinoma
2. Improving survival after resection of hepatocellular carcinoma: Characteristics and current status of surgical treatment of primary liver cancer in Japan
3. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal obstruction: A prospective controlled study
4. Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials
5. Hepatic resection with tumor thrombectomy for hepatocellular carcinoma with tumor thrombi in the major vasculatures
6. A surgically treated long-term survivor of hepatocellular carcinoma with tumor thrombi in the trunk of the portal vein
7. Hepatic artery embolization in 120 patients with unresectable hepatoma
8. Therapeutic embolization of the hepatic artery: A review of 75 procedures
9. Primary treatment of hepatocellular carcinoma by arterial chemoembolization
10. Hepatocellular carcinoma with portal tumor thrombus: Analysis of factors determining prognosis
11. Phase I clinical trial of combined therapy with 5-FU (NSC 19893) and cis-platinum (II) diamminedichloride (NSC 119875)
12. Inhibition of amino acid transport by cis-diamminedichloroplatinum (II) derivatives in L1210 murine leukemia cells
13. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells
14. Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo
15. Pilot trial of prolonged continuous-infusion 5-fluorouracil and weekly cisplatin in advanced colorectal cancer
16. Continuous infusion 5-FU and weekly low dose cisplatin in metastatic gastrointestinal malignancies
17. Low-dose continuous infusion 5-fluorouracil and cisplatin: Phase II evaluation in advanced colorectal carcinoma
18. A phase II study of combination therapy with 5′-deoxy-5-fluorouridine and cisplatin in the treatment of advanced gastric cancer with primary foci
19. The efficacy of continuous local arterial infusion of 5-fluorouracil and cisplatin through an implanted reservoir for severe advanced hepatocellular carcinoma
20. A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein
21. Transection of the oesophagus for bleeding oesophageal varices
22. The general rules for the clinical and pathological study of primary liver cancer
23. Chemoembolization
24. Adjuvant hepatic arterial infusion chemotherapy after radical hepatectomy for hepatocellular carcinoma: Results of long-term follow-up
25. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis